Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals

Description

Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals download, Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals review, Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals free

Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals

Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.

This recording will update and increase your knowledge of:

• Neurobiological underpinnings of major DSM-5® diagnoses
• Effects and side effects of drugs used to treat these diagnoses
• Responsibilities of the non-prescribing therapist to clients taking psychiatric medication

Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this recording is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders.

You will leave this recording with knowledge and confidence regarding effective and safe application of pharmacological drugs.

Speaker
Alan S. Bloom, PhD, is professor of pharmacology and toxicology at the Medical College of Wisconsin where he teaches psychopharmacology to medical students and neuroscience graduate students. He earned a joint PhD in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases.

Dr. Bloom has conducted extensive research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). He also directed research on the cognitive effects of chemotherapy drugs administered to women with breast cancer, commonly known as “chemo-brain”. His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA Center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin.

Dr. Bloom is a strong and experienced presenter providing lively, information-packed seminars. He encourages the active learning of participants through application of the material in case studies and problem-based learning. In 1997 he was elected to membership in the Medical College of Wisconsin Society of Teaching Scholars.

Speaker Disclosures:
Financial: Dr. Alan Bloom has an employment relationship with the Medical College of Wisconsin. He receives a speaking honorarium and recording royalties from PESI, Inc. Dr. Alan has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Alan Bloom is the Vice Chair of the State of Wisconsin Controlled Substances Board. He is a member of the Organization for Human Brain Mapping, the International Brain Research Organization, and the International Society for Magnetic Resonance in Medicine.

Target Audience

• Counselors
• Psychotherapists
• Psychologists
• Social Workers
• Nurse Practitioners
• Case Managers
• Marriage & Family Therapists
• Addiction Counselors
• Nurses
• Clinical Nurse Specialists
• Pharmacists
• School Psychologists
• Occupational Therapists
• Occupational Therapy Assistants
• Other Mental Health Professionals

Outline

PSYCHOPHARMACOLOGICAL FOUNDATIONS

Core Pharmacological Principles

• Brain structures & circuits involved in:
  Emotional regulation
  Executive function & inhibitory control
  Reward & pleasure
  Learning & memory
• Receptors and neurotransmitters important in the actions of psychopharmacological agents
  Biogenic amines
  Excitatory & inhibitory neurotransmitters
  Endorphins & endocannabinoids

Your Role in Combined Psychological & Pharmacological Treatments

• Collaboration & communication with prescribing professionals
• Managing the combined treatments
  Referrals for medication
  Client psycho-education
  Monitoring drug effects & side effects
  Promoting adherence to combined treatments

DRUGS USED IN THE TREATMENT OF DSM-5® MENTAL DISORDERS
Depressive Disorders

• Neurobiology of depression
• Drugs used to treat depressive disorders
  Selective Serotonin Reuptake inhibitors (SSRIs)
  – Effects, side effects and cautions
  – Suicide risk & discontinuation syndrome
  – Serotonin syndrome
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  Effects, side effects, and cautions
• Atypical antidepressant agents
  Effects, side effects, and cautions
• Tricyclic antidepressants (TCAs)
  Effects, side effects, and cautions
  Why were newer drugs needed?
• MAO inhibitors
  Effects, side effects, and cautions
• Choosing an antidepressant
• What if first-line antidepressants do not work?Augmentation with antipsychotics
• What about herbs like St. John’s Wort?

Schizophrenia Spectrum Disorders

• Biological theories of schizophrenia
• ”Typical” & “atypical” antipsychotic drugs
  Effects, side effects & cautions – similarities & differences
• Latest evidence-based comparisons
• Drugs for treatment-resistant schizophrenia
• Other uses of antipsychotic drugs

Bipolar Disorders

• Biological theories for bipolar disorders
• Drugs used to treat bipolar disorders
  A prototype agent-lithium
  – Effects, side effects & cautions
• Anticonvulsants
  – Effects, side effects & cautions
• Antipsychotics – approved agents
• Combination drug therapy

Anxiety, Obsessive-Compulsive & Sleep-Wake Disorders

• The neurobiology of anxiety-related disorders
• The structure of sleep
• Drugs used in the treatment of anxiety & insomnia
  Benzodiazepines & Benzodiazepine-like drugs
  Misuse of these drugs in treatment
  SSRI’s & other drugs used to treat anxiety

Attention-Deficit/Hyperactivity Disorder & Neurocognitive Disorders (Dementia)

• ADHD
  Psycho-stimulants
  – Effects, side effects & cautions
  Alpha-Adrenergic Agonists
• Major neurocognitive disorders
  Drugs used in the treatment of cognitive impairment
  Future treatments

Prescription Drug Abuse

• Mental disorders & risk of comorbid prescription drug abuse
• Classes of drugs that are frequently abused
  Stimulants
  Sedative-hypnotics
  Opiates
• Strategies for the prevention & early identification of prescription drug abuse

LIMITATIONS OF RESEARCH AND POTENTIAL RISKS

Objectives

1. Communicate the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
2. Evaluate the role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
3. Analyze the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
4. Analyze the effects and side effects of various psychotropic medications, including antipsychotics, antidepressants, benzodiazepines and anticonvulsants.
5. Determine the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.
6. Implement methods for prevention and early identification of prescription drug abuse among clients.

Frequently Asked Questions:

1. Innovative Business Model:
   • Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
2. The Legal Landscape: Yes and No:
   • The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
3. Quality Assurance: Unveiling the Real Deal:
   • Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
     • No coaching calls or scheduled sessions with the author.
     • No access to the author’s private Facebook group or web portal.
     • No entry to the author’s exclusive membership forum.
     • No direct email support from the author or their team.

   We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.

Refund is acceptable:

• Firstly, item is not as explained
• Secondly, Item do not work the way it should.
• Thirdly, and most importantly, support extension can not be used.

Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.